tiprankstipranks
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Financial Statements

Compare
152 Followers

Iradimed Financial Overview

Iradimed's market cap is currently $724.16M. The company's EPS TTM is $1.503; its P/E ratio is 38.09; and it has a dividend yield of 0.79%. Iradimed is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 65.56M$ 53.30M$ 41.81M$ 31.72M$ 38.52M
Gross Profit$ 50.16M$ 41.28M$ 32.05M$ 23.57M$ 29.70M
Operating Income$ 20.04M$ 15.63M$ 9.82M$ -756.09K$ 8.65M
EBITDA$ 20.80M$ 16.30M$ 11.22M$ 582.73K$ 9.89M
Net Income$ 17.19M$ 12.83M$ 9.33M$ 1.37M$ 9.63M
Balance Sheet
Cash & Short-Term Investments$ 49.76M$ 57.96M$ 62.50M$ 51.98M$ 46.25M
Total Assets$ 92.16M$ 85.51M$ 82.88M$ 71.07M$ 66.73M
Total Debt$ 2.04M$ 2.21M$ 2.48M$ 2.72M$ 2.96M
Net Debt$ -47.72M$ -55.76M$ -59.52M$ -47.35M$ -40.53M
Total Liabilities$ 20.74M$ 11.84M$ 10.71M$ 9.68M$ 11.20M
Stockholders' Equity$ 71.42M$ 73.67M$ 72.17M$ 61.38M$ 55.52M
Cash Flow
Free Cash Flow$ 5.46M$ 8.17M$ 10.52M$ 5.18M$ 9.75M
Operating Cash Flow$ 13.47M$ 10.04M$ 11.26M$ 5.82M$ 10.23M
Investing Cash Flow$ -8.01M$ -1.37M$ 648.24K$ 246.97K$ 3.20M
Financing Cash Flow$ -13.66M$ -12.71M$ 24.43K$ 522.48K$ 2.02M
Currency in USD

Iradimed Earnings and Revenue History

Iradimed Debt to Assets

Iradimed Cash Flow

Iradimed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis